BioCentury | Sep 19, 2016
Company News

Lundbeck neurology, generics news

...from the European Commission to fine Lundbeck for anticompetitive activity related to Lundbeck’s antidepressant Celexa citalopram...
BioCentury | Apr 21, 2016
Targets & Mechanisms

Structural SERT-ainty

...SSRIs citalopram and its S-enantiomer, escitalopram, while at the company. Lundbeck and Allergan plc market Celexa...
...hard to assess critically. What the structure shows is that there are two distinct ways citalopram...
...construct bound to the generic SSRI antidepressant escitalopram - the S-enantiomer of the generic SSRI citalopram...
BioCentury | Apr 18, 2016
Company News

Epic Pharma, Humanwell Healthcare Group, PuraCap Pharmaceutical LLC deal

...marketed as Norvasc by Pfizer Inc. (NYSE:PFE, New York, N.Y.); depression drug citalopram, marketed as Celexa...
BioCentury | Jul 17, 2014
Distillery Techniques

Technology: Markers

...controls. In human neural progenitor cells, chronic treatment with the marketed antidepressants imipramine or Celexa citalopram...
...in remitter patients than nonresponders and controls, and miR-1202 levels were higher in patients after Celexa...
...miR-1202 with other antidepressants and in wider patient populations. Imipramine is a generic tricyclic antidepressant. Citalopram...
BioCentury | Jun 19, 2014
Distillery Therapeutics

Indication: Neurology

...APP) and presenilin 1 (PSEN1; PS1) and free of b-amyloid (Ab)-related pathology, the SSRI Celexa citalopram...
...24 hours. In a cohort of 23 healthy human subjects between ages 18 and 50, citalopram...
...to identify human subjects with high baseline levels of Ab that could benefit from SSRIs. Citalopram...
BioCentury | Sep 9, 2013
Company News

Lundbeck neurology news

...to fine Lundbeck €93.8 million ($124 million) for anticompetitive activity related to Lundbeck's antidepressant Celexa citalopram...
BioCentury | Jun 24, 2013
Company News

Actavis, Lundbeck, Merck KGaA, Ranbaxy, Xellia Pharmaceuticals A/S, Zoetis neurology news

...antidepressant Celexa citalopram violated competition law. The commission said that after Lundbeck's basic patents covering Celexa...
...for Celexa. The EC has investigated whether Lundbeck's agreements have delayed the entry of generic citalopram...
...the EC issued a statement of objections regarding the deals. Lundbeck does not break out Celexa...
BioCentury | Nov 5, 2012
Strategy

Racing to rebuild AZ

...Phase IIb results were announced showing the compound plus citalopram had a six-point improvement over citalopram...
BioCentury | Jul 30, 2012
Company News

Lundbeck neurology news

...Commission a statement of objections regarding deals with four generic companies for Lundbeck's antidepressant Celexa citalopram...
...for Celexa. The EC has investigated whether Lundbeck's agreements have delayed the entry of generic citalopram...
BioCentury | Dec 5, 2011
Strategy

Lundbeck psyched up

...only in neurology, and partner Forest Laboratories Inc. markets the psychiatry drugs Lexapro and Celexa citalopram...
...Japan Grants Mochida exclusive development and commercialization rights 2000-08 Abbott Laboratories (NYSE:ABT) Depression drugs Celexa citalopram...
Items per page:
1 - 10 of 143